A Massachusetts-based biotech company is stealing the show so far during Tuesday’s session after it announced that its investigational drug IMM-1-104 has received orphan...

To read the full story on AllPennyStocks.com, click here.

Immuneering (NASDAQ:IMRX)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Immuneering Charts.
Immuneering (NASDAQ:IMRX)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Immuneering Charts.